Skip to main content
. 2021 Jun 23;41(12):3141–3156. doi: 10.1177/0271678X211026771

Figure 1.

Figure 1.

Major pathways for familial vascular diseases with brain AVMs (Hereditary Hemorrhagic Telangiectasis (HHT) and Capillary Malformation-Ateriovenous Malformation (CM-AVM)), sporadic brain AVM, and therapeutic targets. *Somatic mutations, and **germline mutations, and ***germline and somatic mutations identified in vascular malformations.